C12Y 301/27008
Ribonuclease v
Official title: Ribonuclease V (3.1.27.8)
C12Y301/27008 (Ribonuclease v) appears on 3 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 4
- Assignees
- 5
- Inventors
- 20
- Latest grant
- 11 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 1 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Methods for mapping personalized translatome11 Nov 2025US 12,467,048 B2Northwestern University
- Preeclamptic placental mesenchymal stem cell conditioned medium for use in the treatment of a tumour17 Apr 2018US 9,943,548 B2CORION BIOTECH S/r.L.
- Pharmaceutical composition for treatment of corneal endothelial wounds containing angiogenin9 Jun 2015US 9,050,301 B2Chung-Ang University Industry-Academy Cooperation Foundation
- Novel Variants of Endonuclease V and Uses Thereof28 Dec 2023US 2023/0416708 A1
- Methods for mapping personalized translatome7 Jul 2022US 2022/0213468 A1Northwestern University
- Preeclamptic Placental Mesenchymal Stem Cell Conditioned Medium for Use in the Treatment of a Tumour10 Sep 2015US 2015/0250823 A1CORION BIOTECH S/r.L.
- Pharmaceutical composition for treatment of corneal endothelial wounds containing angiogenin26 Mar 2015US 2015/0086527 A1Chung-Ang University Industry-Academy Cooperation Foundation
Most cited
By later US patents